Skip to main navigation Skip to search Skip to main content

Arbekacin as an alternative drug to teicoplanin for the treatment of MRSA infection

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1047-1048
Number of pages2
JournalYonsei Medical Journal
Volume57
Issue number4
DOIs
StatePublished - 2016.07

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Cite this